Trial Profile
Randomized parallel group trial of the efficacy and safety of ezetimibe with a statin [HMG-CoA reductase inhibitors] versus statin dose doubling in patients with persistent primary hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Organon
- 28 Apr 2008 New trial record.